N-((4-FLUOROPHENYL)METHYL)-1,6-DIHYDRO-5-HYDROXY-2-(1-METHYL-1-(((5-METHYL-1,3,4-OXADIAZOL-2-YL)CARBONYL)AMINO)ETHYL)-6-OXO-4-PYRIMIDINECARBOXAMIDE
UNII RZ3ZBW563D
Substance Identification & Data
This profile provides standardized clinical and technical data for N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RZ3ZBW563D.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1446223-96-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H19FN6O5 FDSKHNQDEGJGEI-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.